BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28420549)

  • 21. Impacts of non-recovery of trastuzumab-induced cardiomyopathy on clinical outcomes in patients with breast cancer.
    Yoon HJ; Kim KH; Kim HY; Park H; Cho JY; Hong YJ; Park HW; Kim JH; Ahn Y; Jeong MH; Cho JG; Park JC
    Clin Res Cardiol; 2019 Aug; 108(8):892-900. PubMed ID: 30737527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence of left ventricular dysfunction in patients with restored idiopathic dilated cardiomyopathy.
    Park JS; Kim JW; Seo KW; Choi BJ; Choi SY; Yoon MH; Hwang GS; Tahk SJ; Shin JH
    Clin Cardiol; 2014 Apr; 37(4):222-6. PubMed ID: 24452755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study.
    Morales MA; Neglia D; L'Abbate A
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):778-82. PubMed ID: 18607240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left Ventricular Torsion - A New Echocardiographic Prognosticator in Patients With Non-Ischemic Dilated Cardiomyopathy.
    Rady M; Ulbrich S; Heidrich F; Jellinghaus S; Ibrahim K; Linke A; Sveric KM
    Circ J; 2019 Feb; 83(3):595-603. PubMed ID: 30662022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between Myocardial Extracellular Space Expansion Estimated with Post-Contrast T1 Mapping MRI and Left Ventricular Remodeling and Neurohormonal Activation in Patients with Dilated Cardiomyopathy.
    Yoon JH; Son JW; Chung H; Park CH; Kim YJ; Chang HJ; Hong GR; Kim TH; Ha JW; Choi BW; Rim SJ; Chung N; Choi EY
    Korean J Radiol; 2015; 16(5):1153-62. PubMed ID: 26355278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
    Sarli B; Topsakal R; Kaya EG; Akpek M; Lam YY; Kaya MG
    J Investig Med; 2013 Apr; 61(4):728-32. PubMed ID: 23429699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and prognostic relevancy of left ventricular trabeculation assessed by cardiac magnetic resonance in patients with dilated cardiomyopathy.
    Mazurkiewicz Ł; Petryka J; Śpiewak M; Miłosz-Wieczorek B; Małek ŁA; Jasińska A; Jarmus E; Marczak M; Misko J; Grzybowski J
    Kardiol Pol; 2017; 75(8):794-803. PubMed ID: 28541593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of disease progression in pediatric dilated cardiomyopathy.
    Molina KM; Shrader P; Colan SD; Mital S; Margossian R; Sleeper LA; Shirali G; Barker P; Canter CE; Altmann K; Radojewski E; Tierney ES; Rychik J; Tani LY;
    Circ Heart Fail; 2013 Nov; 6(6):1214-22. PubMed ID: 24132734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy.
    Dini FL; Cortigiani L; Baldini U; Boni A; Nuti R; Barsotti L; Micheli G
    Am J Cardiol; 2002 Mar; 89(5):518-23. PubMed ID: 11867034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart failure biomarkers in patients with dilated cardiomyopathy.
    Bielecka-Dabrowa A; von Haehling S; Aronow WS; Ahmed MI; Rysz J; Banach M
    Int J Cardiol; 2013 Oct; 168(3):2404-10. PubMed ID: 23416015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome and prognostic value of N-terminal pro-brain natriuretic peptide and high-sensitivity C-reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy.
    Feng J; Tian P; Liang L; Chen Y; Wang Y; Zhai M; Huang Y; Zhou Q; Zhao X; Zhao L; Huang B; Huang L; Zhang Y; Zhang J
    ESC Heart Fail; 2022 Jun; 9(3):1625-1635. PubMed ID: 35243815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
    Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
    Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation between athlete's heart and dilated cardiomyopathy in athletic individuals.
    Millar LM; Fanton Z; Finocchiaro G; Sanchez-Fernandez G; Dhutia H; Malhotra A; Merghani A; Papadakis M; Behr ER; Bunce N; Oxborough D; Reed M; O'Driscoll J; Tome Esteban MT; D'Silva A; Carr-White G; Webb J; Sharma R; Sharma S
    Heart; 2020 Jul; 106(14):1059-1065. PubMed ID: 32341137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy: A CMR Study.
    Amzulescu MS; Rousseau MF; Ahn SA; Boileau L; de Meester de Ravenstein C; Vancraeynest D; Pasquet A; Vanoverschelde JL; Pouleur AC; Gerber BL
    JACC Cardiovasc Imaging; 2015 Aug; 8(8):934-46. PubMed ID: 26189121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left Atrial Volume as a Predictor of Left Ventricular Functional Recovery in Patients With Dilated Cardiomyopathy and Absence of Delayed Enhancement in Cardiac Magnetic Resonance.
    Moon J; Shim CY; Kim YJ; Park S; Kang SM; Chung N; Ha JW
    J Card Fail; 2016 Apr; 22(4):265-71. PubMed ID: 26700660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hazards of ventricular pre-excitation to left ventricular systolic function and ventricular wall motion in children: analysis of 25 cases.
    Guo B; Dai C; Li Q; Li W; Han L
    Cardiol Young; 2019 Mar; 29(3):380-388. PubMed ID: 30767835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Clinical Course and Outcomes between Dilated and Hypokinetic Non-Dilated Cardiomyopathy.
    Dziewięcka E; Winiarczyk M; Wiśniowska-Śmiałek S; Karabinowska-Małocha A; Robak J; Kaciczak M; Baranowski F; Rubiś P
    Cardiology; 2023; 148(5):395-401. PubMed ID: 37311443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posterior restoration procedures and the long-term results in indicated patients with dilated cardiomyopathy †.
    Isomura T; Hirota M; Notomi Y; Hoshino J; Kondo T; Takahashi Y; Yoshida M
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):725-31; discussion 731. PubMed ID: 25736271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implications of serial serum N-terminal prohormone brain natriuretic peptide levels in the prediction of outcome in children with dilated cardiomyopathy.
    Kim G; Lee OJ; Kang IS; Song J; Huh J
    Am J Cardiol; 2013 Nov; 112(9):1455-60. PubMed ID: 24035042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.